Case Name: In Re Bendamustine Consolidated Cases, No. 13-2046-GMS, 2016 U.S. Dist. LEXIS 75624 (D. Del. June 10, 2016) (Sleet, J.) -
Drug Product and Patent(s)-in-Suit: Treanda® (bendamustine HCl); U.S. Patents Nos....more
Case Name: Intendis GMBH et al. v. Glenmark Pharms. Inc., USA, 822 F.3d 1355 (Fed. Cir. May 16, 2016) (Circuit Judges Prost, Moore, and Taranto presiding; Opinion by Moore, J.) (Appeal from D. Del., Robinson, J.) -
Drug...more
7/27/2016
/ Abbreviated New Drug Application (ANDA) ,
Bayer ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Hatch-Waxman ,
Patent Infringement ,
Patent Litigation ,
Patent-in-Suit ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Prior Art
Intellectual Ventures I LLC, et al. v. Citigroup, Inc., et al.
Case Number: 1:14-cv-04638 -
Citigroup moved to stay this case, which involved five patents related to cyber security and the protection of customer...more
CDx Diagnostics, Inc. et al. v. U.S. Endoscopy Group, Inc. et al.
Case Number: 7:13-cv-05669-NSR -
Judge Román stayed the litigation after the PTAB instituted IPR Case Nos. IPR2014-00639 and IPR2014-00641 for...more
Hockeyline, Inc. v. Stats LLC
Case Number: 2:13-cv-01446-CM
Judge McMahon, following the parties’ joint motion after the PTAB instituted IPR Case No. IPR2014-00510 for the patent-in-suit, U.S. Patent No....more
Defendant Ablexis requested that the court compel the production of documents associated with the prosecution of non-U.S. patent applications related to the patent-in-suit. The court said that a defendant’s statement that the...more